Global Epidemiology of Campylobacter Infection
Citations
925 citations
306 citations
Cites background from "Global Epidemiology of Campylobacte..."
...…and it was proved that AgNPs are effective against multidrug resistant bacteria such as multidrug resistant E. coli (Paredes et al., 2014; Kar et al., 2016), multidrug resistant strain of Pseudomonas aeruginosa (Durairaj et al., 2012), methicillin-resistant Staphylococcus aureus (MRSA)…...
[...]
296 citations
284 citations
246 citations
Cites background from "Global Epidemiology of Campylobacte..."
...could cause symptoms associated with campylobacteriosis, and 9 × 104 bacteria is considered the optimum infective dose [27]....
[...]
...Symptoms disappear within 5–7 days [27,51]....
[...]
...This movement is possible due to a single, polar flagellum positioned on one or both ends of the cell [27,28]....
[...]
...Possible complications include: peripheral neuropathies, including the Guillain–Barré Syndrome (GBS, neurological disorder characterised by weakness of limbs, possible involvement of respiratory muscles, anaemia, and sensory loss); reactive arthritis (REA, involving knees and ankles, occurring about a month after infection and developing for as long as 5 years); and functional intestinal disorders, including irritable bowel syndrome (IBS) [27,46,52,53]....
[...]
References
20 citations
"Global Epidemiology of Campylobacte..." refers background or result in this paper
...Similarly, in Germany, the prevalence of campylobacteriosis in 2011 was similar to the data from 2001; in contrast, over the same period, the prevalence of salmonellosis had decreased (48)....
[...]
...In 2011, there were 70,560 reported cases of campylobacteriosis, a prevalence higher than that reported for Salmonella, Shigella, Yersinia, and Listeria infections (48)....
[...]
20 citations
20 citations
20 citations
"Global Epidemiology of Campylobacte..." refers background in this paper
...4 per 100,000 inhabitants—an incidence which had doubled in 2002 (42)....
[...]
20 citations